Rheumnow Podcast

Dr. Jack Cush reviews the journal reports and news from the past week on RheumNow.com. This week blockbuster drugs, opioids in rheumatology and nontreatment of inflammatory arthritis?

Dr. Jack Cush reviews the news and journal reports from the past 2 weeks.  This weeks question - Can we prevent gout, ILD or psoriasis?

In lieu of this weeks podcast, Dr. Jack Cush records his  "Life Lessons (that keep changing) in Rheumatology Lecture. A lecture recently cancelled because some of this content was objectionable?  (I dont think so!)

The 2023 EULAR recommendations for the management of lupus advocate for a treat-to-target approach, aiming for remission or low-level disease activity state.3 In this video, Dr. Michelle Petri summarizes the clinical criteria to attain these targets, and their association with reducing organ damage accrual.

Dr. Jack Cush muses on the news, journal reports, FDA announcements and the 2024 BSR abstracts just released.

Experts David Karp, Michelle Kahlenberg, and Andrea Fava share insights on rethinking preclinical lupus, treating lupus flares, and using biomarkers for SLE management. Topics include B cell development, treatment approaches, complement activation, SLE therapy, biomarkers in lupus nephritis, and personalized medicine.